1237494-98-2

Upstream product

• 39637-74-6 (1S)-(-)-camphanic chloride 
• 350-51-6 3-fluorostyrene 
• 263893-75-0 ethyl 2-(3-fluorophenyl)cyclopropane carboxylate 
• 1157561-41-5 rac-trans-2-(3-fluorophenyl)-cyclopropanecarboxylic acid 
• 1157139-62-2 (1R,2S)-2-(3-Fluoro-phenyl)-cyclopropylamine 

Downstream Products

• 220353-83-3 (1R,2S)-2-(3-fluorophenyl)cyclopropanamine 
• 1237495-06-5 (3R,4R)-tert-butyl 3-((6-(bis(tert-butoxycarbonyl)amino)-4-methylpyridin-2-yl)methyl)-4-(2-((1S,2R)-2-(3-fluorophenyl)cyclopropylamino)ethoxy)pyrrolidine-1-carboxylate 
• 1424142-91-5 (3R,4R)-tert-butyl 3-((6-(benzyl(tert-butoxycarbonyl)amino)-4-methylpyridin-2-yl)methyl)-4-(2-((tert-butoxycarbonyl)((1S,2R)-2-(3-fluorophenyl)cyclopropyl)amino)ethoxy)pyrrolidine-1-carboxylate 

Relevant academic research and scientific papers

Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase

Inhibitors of neuronal nitric oxide synthase have been proposed as therapeutics for the treatment of different types of neurological disorders. On the basis of a cis-3,4-pyrrolidine scaffold, a series of trans-cyclopropyl- and methyl-containing nNOS inhib

POTENT AND SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS WITH IMPROVED MEMBRANE PERMEABILITY

Compounds and related compositions and methods as can be used to inhibit neuronal nitric oxide synthase and as can be employed in the treatment of various neurodegenerative diseases.